African American race was associated with an increased risk of complications following venous thromboembolism

Journal of Clinical Epidemiology

Volumn 60, Issue 4, 2007, Pages 410-416

  Aujesky, Drahomir ^a   Long, Judith A ^b,c,d   Fine, Michael J ^b,e   Ibrahim, Said A ^b,e  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Anticoagulation; Equity; Outcomes; Quality; Race; Venous thromboembolism

Indexed keywords

HEPARIN; WARFARIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLEEDING; DEATH; FEMALE; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE; RECURRENT DISEASE; RETROSPECTIVE STUDY; VENOUS THROMBOEMBOLISM;

AFRICAN AMERICANS; ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; TREATMENT OUTCOME; VENOUS THROMBOSIS; WARFARIN;

EID: 33847393720     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2006.06.023     Document Type: Article

References (37)

1. White R.H. The epidemiology of venous thromboembolism. Circulation 107 (2003) I4-I8
2. Kearon C. Natural history of venous thromboembolism. Circulation 107 (2003) I22-I30
3. Bergqvist D., Jendteg S., Johansen L., Persson U., and Odegaard K. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med 126 (1997) 454-457
4. Lilienfeld D.E. Decreasing mortality from pulmonary embolism in the United States, 1979-1996. Int J Epidemiol 29 (2000) 465-469
5. Siddique R.M., Siddique M.I., and Rimm A.A. Trends in pulmonary embolism mortality in the US elderly population: 1984 through 1991. Am J Public Health 88 (1998) 478-480
6. Stein P.D., Kayali F., and Olson R.E. Estimated case fatality rate of pulmonary embolism, 1979 to 1998. Am J Cardiol 93 (2004) 1197-1199
7. White R.H., Beyth R.J., Zhou H., and Romano P.S. Major bleeding after hospitalization for deep-venous thrombosis. Am J Med 107 (1999) 414-424
8. Horlander K.T., Mannino D.M., and Leeper K.V. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med 163 (2003) 1711-1717
9. Smedley B.D., Stith A.Y., and Nelson A.R. Unequal treatment: confronting racial and ethnic disparities in health care (2003), National Academies Press, Washington, D.C.
10. Epstein A.M., and Ayanian J.Z. Racial disparities in medical care. N Engl J Med 344 (2001) 1471-1473
11. Stein P.D., Hull R.D., Patel K.C., Olson R.E., Ghali W.A., Alshab A.K., et al. Venous thromboembolic disease: comparison of the diagnostic process in blacks and whites. Arch Intern Med 163 (2003) 1843-1848
12. Hyers T.M., Agnelli G., Hull R.D., Weg J.G., Morris T.A., Samama M., et al. Antithrombotic therapy for venous thromboembolic disease. Chest 114 (1998) 561S-578S
13. Gallus A., Jackaman J., Tillett J., Mills W., and Wycherley A. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet 2 (1986) 1293-1296
14. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society. Lancet 340 (1992) 873-876
15. Rosiello R.A., Chan C.K., Tencza F., and Matthay R.A. Timing of oral anticoagulation therapy in the treatment of angiographically proven acute pulmonary embolism. Arch Intern Med 147 (1987) 1469-1473
16. Mohiuddin S.M., Hilleman D.E., Destache C.J., Stoysich A.M., Gannon J.M., and Sketch Sr. M.H. Efficacy and safety of early versus late initiation of warfarin during heparin therapy in acute thromboembolism. Am Heart J 123 (1992) 729-732
17. Hansson P.O., Sorbo J., and Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 160 (2000) 769-774
18. Kearon C., Julian J.A., Newman T.E., and Ginsberg J.S. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med 128 (1998) 663-677
19. Hull R.D., Raskob G.E., Rosenbloom D., Panju A.A., Brill-Edwards P., Ginsberg J.S., et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 322 (1990) 1260-1264
20. Hull R.D., Hirsh J., Carter C.J., Jay R.M., Dodd P.E., Ockelford P.A., et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 98 (1983) 891-899
21. Remy-Jardin M., Remy J., Wattinne L., and Giraud F. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique-comparison with pulmonary angiography. Radiology 185 (1992) 381-387
22. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
23. Hull R.D., Raskob G.E., Brant R.F., Pineo G.F., and Valentine K.A. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med 157 (1997) 2562-2568
24. Anand S., Ginsberg J.S., Kearon C., Gent M., and Hirsh J. The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin. Arch Intern Med 156 (1996) 1677-1681
25. Anand S.S., Bates S., Ginsberg J.S., Levine M., Buller H., Prins M., et al. Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times. Arch Intern Med 159 (1999) 2029-2032
26. Raschke R.A., Reilly B.M., Guidry J.R., Fontana J.R., and Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 119 (1993) 874-881
27. Prandoni P., Lensing A.W., Prins M.H., Frulla M., Marchiori A., Bernardi E., et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 141 (2004) 249-256
28. Linkins L.A., Choi P.T., and Douketis J.D. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 139 (2003) 893-900
29. Hylek E.M., Regan S., Henault L.E., Gardner M., Chan A.T., Singer D.E., et al. Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis. Arch Intern Med 163 (2003) 621-627
30. Arnsten J.H., Gelfand J.M., and Singer D.E. Determinants of compliance with anticoagulation: a case-control study. Am J Med 103 (1997) 11-17
31. Ganz D.A., Glynn R.J., Mogun H., Knight E.L., Bohn R.L., and Avorn J. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med 15 (2000) 776-781
32. Hyers T.M., Agnelli G., Hull R.D., Morris T.A., Samama M., Tapson V., et al. Antithrombotic therapy for venous thromboembolic disease. Chest 119 (2001) 176S-193S
33. Ansell J., Hirsh J., Poller L., Bussey H., Jacobson A., and Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 204S-233S
34. Wheeler A.P., Jaquiss R.D., and Newman J.H. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. Arch Intern Med 148 (1988) 1321-1325
35. Whittle J., Johnson P., and Localio A.R. Anticoagulation therapy in patients with venous thromboembolic disease. J Gen Intern Med 13 (1998) 373-378
36. Aujesky D.A., Cornuz J., Bosson J.L., Bounameaux H., Emmerich J., Hull R.D., et al. Uptake of new treatment strategies for deep vein thrombosis: an international audit. Int J Qual Health Care 16 (2004) 1-8
37. Dolovich L.R., Ginsberg J.S., Douketis J.D., Holbrook A.M., and Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med 160 (2000) 181-188